Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 10Neoplasms 7Motor Activity 5Rectal Neoplasms 3Pain, Postoperative 3Vomiting 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nausea 2Lung Neoplasms 2Liver Diseases 2Leukemia, Myeloid, Acute 2Fatigue 2Colorectal Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Ulcer 1Stomatitis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Postoperative Cognitive Complications 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pediatric Brain Tumor 1Pathologic Processes 1Papillomavirus Infections 1Pain 1Osteolysis 1Multiple Myeloma 1Malnutrition 1

Interventions

Aminolevulinic Acid 5Fluorouracil 3tirbanibulin 2Photochemotherapy 2Niacinamide 2Cryotherapy 2methyl 5-aminolevulinate 1green tea extract polyphenone E 1dehydroftorafur 1calcipotriene 1Therapeutics 1Sunscreening Agents 1Powders 1Ointments 1Imipramine 1Control Groups 1Biopsy 1BF-200 ALA 1Aluminum Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Actinic × Control Groups × 1 year × Clear all
NCT07335003 2026-01-12

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Cosmetique Active International

Phase NA Recruiting
80 enrolled
Dermatologic

Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡